Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines

doi:10.3748/wjg.v24.i4.511

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7054)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

497

WORD

245

HTML

4276

Figures (1-4)

177

Tables (1-3)

158

Sum=5353

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

929

Download

772

Sum=1701

Jan 28, 2018 (publication date) through Jun 16, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jan 28, 2018; 24(4): 511-518
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.511

Table 1 Demographic data and treatment of 96 patients

Patient	n
Gender (females/males)	32/64
Median age at presentation	28
Range	10-71
UC; CD	67; 29
Treatment
6-MP (yes/no)	96/0
5-ASA (yes/no)	90/6
Steroid (yes/no)	55/41
Anti-TNF drugs (yes/no)	36/60

CD: Crohn’s disease.

Citation: Kojima Y, Hirotsu Y, Omata W, Sugimori M, Takaoka S, Ashizawa H, Nakagomi K, Yoshimura D, Hosoda K, Suzuki Y, Mochizuki H, Omata M. Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines. World J Gastroenterol 2018; 24(4): 511-518
URL: https://www.wjgnet.com/1007-9327/full/v24/i4/511.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i4.511